THE ASSOCIATION BETWEEN ASTHMA DRUGS AND SEVERE LIFE-THREATENING ATTACKS

Citation
Hh. Rea et al., THE ASSOCIATION BETWEEN ASTHMA DRUGS AND SEVERE LIFE-THREATENING ATTACKS, Chest, 110(6), 1996, pp. 1446-1451
Citations number
10
Categorie Soggetti
Respiratory System
Journal title
ChestACNP
ISSN journal
00123692
Volume
110
Issue
6
Year of publication
1996
Pages
1446 - 1451
Database
ISI
SICI code
0012-3692(1996)110:6<1446:TABADA>2.0.ZU;2-O
Abstract
Objectives: To measure the association between asthma drugs and death or ICU admission due to asthma (severe life-threating attack of asthma [SLTA]), and to assess the possibility that these associations may no t be causal but due to the prescription of these drugs to patients wit h more severe disease (confounding), Design: Retrospective cohort stud y of 655 asthmatics who attended an emergency department in 1986 to 19 87 followed till death or May 1989. Methods: Outcome events were death or ICU admission due to asthma (SLTA), All hospital attendances were identified and patients classified at each according to drug exposure and a wide variety of measures of asthma severity. Incidence rates wer e computed as total outcome events divided by person-time contributed for each subject classified according to drug use and asthma severity. Rate ratio (RR) estimates for severe asthma outcomes associated with use as compound to nonuse of asthma drugs were calculated, Severity ma rkers were identified and used to adjust the crude RR estimates, Resul ts: One hundred five SLTAs (15 deaths, 90 ICU admissions) occurred in 66 patients, Like inhaled fenoterol, oral beta-agonists, theophylline, cromolyn, inhaled steroids, and oral steroids were all associated wit h an increased risk of SLTA. When adjusted progressively for measures of severity, these increased risks became insignificant except for cro molyn. Conclusion: Unadjusted RR estimates for severe asthma events co mparing exposure to a particular drug with nonuse are overestimates du e to confounding. Control with two severity markers (hospital admissio n in the last year, use of oral corticosteroid at the time of previous admission) removes some confounding but control for additional severi ty markers not available in previous studies reduces the effect estima tes further, These results suggest that the problem of confounding is substantial in nonrandomized epidemiologic studies of asthma drugs, Pr evious studies reporting RR estimates are likely to be confounded.